HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked neuropsychiatric involvement and dysmorphic features in nemaline myopathy.

AbstractBACKGROUND:
Inherited nemaline myopathy is one of the most common congenital myopathies. This genetically heterogeneous disease is defined by the presence of nemaline bodies in muscle biopsy. The phenotypic spectrum is wide and cognitive involvement has been reported, although not extensively evaluated.
METHODS:
We report two nemaline myopathy patients presenting pronounced central nervous system involvement leading to functional compromise and novel facial and skeletal dysmorphic findings, possibly expanding the disease phenotype.
RESULTS:
One patient had two likely pathogenic NEB variants, c.2943G > A and c.8889 + 1G > A, and presented cognitive impairment and dysmorphic features, and the other had one pathogenic variant in ACTA1, c.169G > C (p.Gly57Arg), presenting autism spectrum disorder and corpus callosum atrophy. Both patients had severe cognitive involvement despite milder motor dysfunction.
CONCLUSION:
We raise the need for further studies regarding the role of thin filament proteins in the central nervous system and for a systematic cognitive assessment of congenital myopathy patients.
AuthorsPaulo Ribeiro Nóbrega, Jorge Luiz de Brito de Souza, Rebeca Bessa Maurício, Anderson Rodrigues Brandão de Paiva, Daniel Aguiar Dias, Clara Gontijo Camelo, Edmar Zanotelli, David Schlesinger, Pedro Braga-Neto, Cristiane Araujo Martins Moreno
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) (Oct 18 2023) ISSN: 1590-3478 [Electronic] Italy
PMID37851294 (Publication Type: Journal Article)
Copyright© 2023. Fondazione Società Italiana di Neurologia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: